If you’re taking an aromatase inhibitor for breast cancer, you’ve probably heard the term VTE thrown around. VTE stands for venous thromboembolism, which includes deep‑vein clots and pulmonary embolisms. It sounds scary, but understanding the link and knowing what to do can keep you on track with your treatment.
Aromatase inhibitors lower estrogen levels in the body. Estrogen helps keep blood vessels flexible, so when its levels drop, the blood can become a bit stickier. Studies show that women on these drugs have a slightly higher chance of developing clots, especially if they already have other risk factors like age, obesity, or a history of clotting.
Most clots form in the leg veins and cause swelling, pain, or a warm feeling. If a piece breaks off and travels to the lungs, it becomes a pulmonary embolism – a medical emergency that can cause shortness of breath, chest pain, or a rapid heartbeat. The good news is that the overall risk is still low, and many people take these medicines without any problems.
1. Stay active. Simple leg movements, short walks, or gentle stretching during the day keep blood flowing. If you’re sitting for long periods (like during a flight), stand up and walk around every hour.
2. Hydrate. Drinking enough water helps keep blood thin enough to move smoothly. Aim for at least eight glasses a day unless your doctor says otherwise.
3. Watch your weight. Extra pounds put extra pressure on leg veins. If you’re carrying extra weight, talk to your doctor about a safe plan to lose a few pounds.
4. Know the signs. Swelling, redness, or pain in one leg should never be ignored. Shortness of breath, chest pain, or a sudden cough could mean a clot traveled to your lungs.
5. Review your meds. Some medicines, like certain pain relievers or hormone therapies, can add to clot risk. Keep a list of all drugs you’re taking and discuss them with your oncologist.
If you notice any warning signs, call your doctor right away. Early treatment with blood thinners can stop a clot from getting bigger and reduce the chance of complications.
Finally, don’t stop your aromatase inhibitor without talking to your doctor. The benefits for breast‑cancer control often outweigh the clot risk, especially when you follow these simple steps. Stay informed, stay active, and keep the conversation open with your healthcare team.
Aug, 23 2025
A clear, up‑to‑date look at how exemestane may affect clotting, what the numbers say, how it compares to other aromatase inhibitors, and practical steps to stay safe.